Poco se conoce acerca de la historia natural o el riesgo de desarrollar melanoma
Svensson J, Lall S, Dickson SL, et al
In Phase 2 research, this pharmacological profile translated into the largest average weight reductions ever reported for a once-weekly peptide, catalyzing widespread interest among endocrinologists, obesity researchers, and metabolic-disease scientists
If you look at the data as a whole and especially the six studies we cite in our editorial the findings suggest that the cardiovascular and metabolic benefits of GLP-1 drugs extend beyond weight loss, indicating other mechanisms, such as anti-inflammatory or kidney and liver effects, may play a major role
Medical guidance during breastfeeding follows a simple rule: If evidence is limited, avoid unnecessary supplementation especially before 3 months postpartum